Biospring Partners was founded in 2020 to invest in companies with the potential to fundamentally shift how technology is utilized across the life sciences sector. Michelle Dipp and Jennifer Lum came together to combine their experience in healthcare, technology, investing and operations to offer a differentiated approach to growth equity.
Expanding the potential of life sciences technology
We focus on identifying long-term themes within life sciences technology. We build trusted partnerships with management teams to support the growth of their businesses.
Sectors we invest in
Biospring invests in growth-stage B2B companies that are driving innovation across the life sciences industry and beyond.
Our Approach
We are a trusted partner that thrives in building long term strategic partnerships. We work closely alongside our companies to broaden their ambition and strengthen their path to growth.
Our Investment Criteria
- $10M+ in annual revenue
- 30%+ revenue growth
- Diverse customer base